2. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 2005;96:1301-6. PMID:
16287449
4. Ruggieri MR, Colton MD, Wang P, Wang J, Smyth RJ, Pontari MA, et al. Human prostate muscarinic receptor subtypes. J Pharmacol Exp Ther 1995;274:976-82. PMID:
7636762
5. Witte LP, Chapple CR, de la Rosette JJ, Michel MC. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol 2008;54:326-34. PMID:
18160204
6. Ventura S, Pennefather J, Mitchelson F. Cholinergic innervation and function in the prostate gland. Pharmacol Ther 2002;94:93-112. PMID:
12191596
7. Roosen A, Wu C, Sui GP, Fry CH. Synergistic effects in neuromuscular activation and calcium-sensitisation in the bladder trigone. BJU Int 2008;101:610-4. PMID:
18070195
8. Roosen A, Wu C, Sui G, Chowdhury RA, Patel PM, Fry CH. Characteristics of spontaneous activity in the bladder trigone. Eur Urol 2009;56:346-53. PMID:
18602741
9. Roosen A, Fry CH, Sui G, Wu C. Adreno-muscarinic synergy in the bladder trigone:calcium-dependent and -independent mechanisms. Cell Calcium 2009;45:11-7. PMID:
18597842
12. Athanasopoulos A, Chapple C, Fowler C, Gratzke C, Kaplan S, Stief C, et al. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction:an update. Eur Urol 2011;60:94-105. PMID:
21497434
13. Chapple CR. Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia. Curr Opin Urol 2010;20:43-8. PMID:
19875964
14. Wu C, Sui G, Fry CH. The role of the L-type Ca
2+ channel in refilling functional intracellular Ca
2+ stores in guinea-pig detrusor smooth muscle. J Physiol 2002;538:357-69. PMID:
11790805
15. Tallarida RJ. An overview of drug combination analysis with isobolograms. J Pharmocol Exp Ther 2006;319:1-7.
16. Cheng HC. The influence of cooperativity on the determination of dissociation constants:examination of the Cheng–Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations. Pharmacol Res 2004;50:21-40. PMID:
15082026
19. Gup DI, Shapiro E, Baumann M, Lepor H. Contractile properties of human prostate adenomas and the development of infravesical obstruction. Prostate 1989;15:105-14. PMID:
2477832
20. Normandin DE, Lodge NJ. Pharmacological characterization of the isolated canine prostate. J Urol 1996;155:1758-61. PMID:
8627879
22. Hedlund H, Andersson KE, Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 1985;134:1291-8. PMID:
2414474
23. Yazawa H, Saita Y, Iida E, Honma Y, Morita T, Honda K. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 1994;152:2173-7. PMID:
7966710
25. White CW, Short JL, Haynes JM, Matsui M, Ventura S. Contractions of the mouse prostate elicited by acetylcholine are mediated by M3 muscarinic receptors. J Pharmacol Exp Ther 2011;339:870-7. PMID:
21885618
26. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 1991;256:727-33. PMID:
1994002
28. Sellers DJ, Yamanishi T, Chapple CR, Couldwell C, Yasuda K, ChessWilliams R. M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol 2000;20:171-6. PMID:
11193006
29. Lazareno S, Birdsall NJ. Pharmacological characterization of acetylcholine-stimulated 35S-GTPgS binding mediated by human muscarinic m1-m4 receptors:antagonist studies. Br J Pharmacol 1993;109:1120-7. PMID:
8401923
30. Hao N, Tian Y, Liu W, Wazir R, Wang J, Liu L, et al. Antimuscarinics and α-blockers or α-blockers monotherapy on lower urinary tract symptoms - a meta-analysis. Urology 2014;83:556-62. PMID:
24361007
32. Drake MJ, Chapple C, Sokol R, Oelke M, Traudtner K, Klaver M, et al. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension. Eur Urol 2015;67:262-70. PMID:
25070148
33. Lenfant L, Pinar U, Roupret M, Mozer P, Chartier-Kastler E, Seisen T. Role of antimuscarinics combined with alpha-blockers in the management of urinary storage symptoms in patients with benign prostatic hyperplasia:an updated systematic review and meta-analysis. J Urol 2023;209:314-24. PMID:
36395428